COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 486: Articles 4851-4860  | Next

Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection
Liu, B., Stepien, S., Qian, J., Gidding, H., Nicopoulos, K., Amin, J., Cheng, A., Macartney, K.
10.1101/2022.12.22.22283869 — Posted: 2022-12-26
Unequal Recovery in Colorectal Cancer Screening Following the COVID-19 Pandemic: A Comparative Microsimulation Analysis
Nascimento de Lima, P., van den Puttelaar, R., Hahn, A. I., Harlass, M., COLLIER, N., Ozik, J., Zauber, A., Lansdorp-Vogelaar, I., Rutter, C.
10.1101/2022.12.23.22283887 — Posted: 2022-12-26
TaME-seq2: Tagmentation-assisted multiplex PCR enrichment sequencing for viral genomic profiling
Hesselberg Lovestad, A., Stosic, M., Costanzi, J.-M., Christiansen, I. K., Aamot, H. V., Ambur, O. H., Rounge, T. B.
10.1101/2022.12.22.22283851 — Posted: 2022-12-26
No patient is the same; lessons learned from antibody repertoire profiling in hospitalized severe COVID-19 patients
Bondt, A., Hoek, M., Dingess, K., Tamara, S., de Graaf, B., Peng, W., den Boer, M. A., Damen, M., Zwart, C., Barendregt, A., van Rijswijck, D. M. H., Grobben, M., Tejjani, K., van Rijswijk, J., Voellmy, F. I., Snijder, J., Fortini, F., Papi, A., Volta, C. A., Campo, G., Contoli, M., van Gils, M. J., Spadaro, S., Rizzo, P., Heck, A. J. R.
10.1101/2022.12.23.22283896 — Posted: 2022-12-26
Omicron BA.5 infects human brain organoids and is neuroinvasive and lethal in K18-hACE2 mice
Stewart, R., Ellis, S. A., Yan, K., Dumenil, T., Tang, B., Nguyen, W., Bishop, C. R., Larcher, T., Parry, R., Sullivan, R. K. P., Lor, M., Khromykh, A. A., Meunier, F. A., Rawle, D. J., Suhrbier, A.
10.1101/2022.12.22.521696 — Posted: 2022-12-25
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up.
Bramante, C. T., Buse, J. B., Liebovitz, D., Nicklas, J., Puskarich, M. A., Cohen, K., Belani, H., Anderson, B., Huling, J. D., Tignanelli, C., Thompson, J., Pullen, M., Siegel, L., Proper, J., Odde, D. J., Klatt, N., Sherwood, N., Lindberg, S., Wirtz, E. L., Krager, A., Beckman, K., Erickson, S., Fenno, S., Hartman, K., Rose, M., Patel, B., Griffiths, G., Bhat, N., Murray, T. A., Boulware, D. R.
10.1101/2022.12.21.22283753 — Posted: 2022-12-24
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 Omicron sub-lineages
Touret, F., Giraud, E., Bourret, J., Donati, F., Tran-Rajau, J., Chiaravalli, J., Lemoine, F., Agou, F., Simon-Loriere, E., Van Der Werf, S., de Lamballerie, X.
10.1101/2022.12.22.521201 — Posted: 2022-12-23
Unbiased single cell spatial analysis localises inflammatory clusters of immature neutrophils-CD8 T cells to alveolar progenitor cells in fatal COVID-19 lungs
Weeratunga, P., Denney, L., Bull, J. A., Repapi, E., Sergeant, M., Etherington, R., Vuppusetty, C., Turner, G. D. H., Clelland, C., Cross, A., Issa, F., de Andrea, C. E., Bermejo, I. M., Sims, D., McGowan, S., Zurke, Y.-X., Ahern, D. J., Gamez, E. C., Whalley, J., Richards, D., Klenerman, P., Monaco, C., Udalova, I. A., Dong, T., Ogg, G., Knight, J., Byrne, H. M., Taylor, S., Ho, L.-P.
10.1101/2022.12.21.22283654 — Posted: 2022-12-23
Evaluation of Covid-19 antigen rapid diagnostic tests for self-testing in Lesotho and Zambia
Bresser, M., Erhardt, R. M., Shanaube, K., Simwinga, M., Mahlatsi, P. A., Belus, J., Schaap, A., Amstutz, A., Gachie, T., Glass, T. R., Kangolo, B., 'Mota, J., Floyd, S., Katende, B., Klinkenberg, E., Ayles, H., Reither, K., Ruperez, M.
10.1101/2022.12.21.22283827 — Posted: 2022-12-23
On the role of different age groups in propagating Omicron epidemics in France
Goldstein, E.
10.1101/2022.12.22.22283867 — Posted: 2022-12-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).